These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 6754595)

  • 1. Quantitative comparisons between carcinogenicity, mutagenicity and electrophilicity of direct-acting N-nitroso compounds and other alkylating agents.
    Bartsch H; Malaveille C; Tomatis L; Brun G; Dodet B; Terracini B
    IARC Sci Publ; 1982; (41):525-32. PubMed ID: 6754595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative comparison of carcinogenicity, mutagenicity and electrophilicity of 10 direct-acting alkylating agents and of the initial O6:7-alkylguanine ratio in DNA with carcinogenic potency in rodents.
    Bartsch H; Terracini B; Malaveille C; Tomatis L; Wahrendorf J; Brun G; Dodet B
    Mutat Res; 1983 Aug; 110(2):181-219. PubMed ID: 6348521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinogenicity and mutagenicity of N-nitroso compounds.
    Lijinsky W
    Mol Toxicol; 1987; 1(1):107-19. PubMed ID: 3329700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenicity studies in Salmonella typhimurium on some carcinogenic N-nitramines in vitro and in the host-mediated assay in rats.
    Khudoley V; Malaveille C; Bartsch H
    Cancer Res; 1981 Aug; 41(8):3205-10. PubMed ID: 7018677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological and chemical properties of alkanediazotates as active species of N-nitroso compounds.
    Ukawa S; Mochizuki M
    IARC Sci Publ; 1991; (105):404-6. PubMed ID: 1855889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpected genetic toxicity to rodents of the N',N'-dimethyl analogues of MNU and ENU.
    Tinwell H; Paton D; Guttenplan JB; Ashby J
    Environ Mol Mutagen; 1996; 27(3):202-10. PubMed ID: 8625956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alkylation of DNA and carcinogenicity of N-nitroso compounds.
    Montesano R; Pegg AE; Margison GP
    J Toxicol Environ Health; 1980; 6(5-6):1001-8. PubMed ID: 6162032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial-mammalian mutagenesis correlations: mechanistic significance for carcinogenesis.
    Bartsch H
    Ann N Y Acad Sci; 1983; 407():351-61. PubMed ID: 6576679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinogenicity and mutagenicity testing of three isomeric N-nitroso-N-methylaminopyridines in rats.
    Preussmann R; Habs M; Pool BL
    J Natl Cancer Inst; 1979 Jan; 62(1):153-6. PubMed ID: 364151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by fatty acids of direct mutagenicity of N-nitroso compounds.
    Takeda K; Ukawa S; Mochizuki M
    IARC Sci Publ; 1991; (105):558-63. PubMed ID: 1855917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenicity of isomeric alkanediazotates, precursors for ultimate alkylating species of carcinogenic N-nitroso compounds.
    Ukawa-Ishikawa S; Sawada A; Kasuya K; Mochizuki M
    Mutat Res; 1998 Jan; 412(1):99-107. PubMed ID: 9508369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships in the mutagenicity of N-substituted derivatives of phenanthrene-9,10-imine.
    Stark AA; Zeiger E; Shtelzer S; Sheradsky T; Lifshitz Y; Blum J
    Mutagenesis; 1986 Jan; 1(1):35-9. PubMed ID: 3325734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative relationship between mutagenic potency in the Ara test of Salmonella typhimurium and carcinogenic potency in rodents. A study of 11 direct-acting monofunctional alkylating agents.
    Roldán-Arjona T; Luque-Romero FL; Ruiz-Rubio M; Pueyo C
    Carcinogenesis; 1990 Jun; 11(6):975-80. PubMed ID: 2189599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenic activity of chemical carcinogens and related compounds in the intraperitoneal host-mediated assay.
    Simmon VF; Rosenkranz HS; Zeiger E; Poirier LA
    J Natl Cancer Inst; 1979 Apr; 62(4):911-8. PubMed ID: 372659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenic and alkylating activities of 3-methyl-1-phenyltriazenes and their possible role as carcinogenic metabolites of the parent dimethyl compounds.
    Malaveille C; Brun G; Kolar G; Bartsch H
    Cancer Res; 1982 Apr; 42(4):1446-53. PubMed ID: 7060018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sites in nucleic acids reacting with alkylating agents of differing carcinogenicity of mutagenicity.
    Singer B
    J Toxicol Environ Health; 1977 Jul; 2(6):1279-95. PubMed ID: 328918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleophilic selectivity as a determinant of carcinogenic potency (TD50) in rodents: a comparison of mono- and bi-functional alkylating agents and vinyl chloride metabolites.
    Barbin A; Bartsch H
    Mutat Res; 1989 Nov; 215(1):95-106. PubMed ID: 2811916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-damaging activity in vivo and bacterial mutagenicity of sixteen hydrazine derivatives as related quantitatively to their carcinogenicity.
    Parodi S; De Flora S; Cavanna M; Pino A; Robbiano L; Bennicelli C; Brambilla G
    Cancer Res; 1981 Apr; 41(4):1469-82. PubMed ID: 7214329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity.
    Zeiger E
    Cancer Res; 1987 Mar; 47(5):1287-96. PubMed ID: 3815340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.